Cyanosis secondary prevention

Jump to navigation Jump to search

Cyanosis Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cyanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cyanosis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cyanosis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cyanosis secondary prevention

CDC on Cyanosis secondary prevention

Cyanosis secondary prevention in the news

Blogs on Cyanosis secondary prevention

Directions to Hospitals Treating Cyanosis

Risk calculators and risk factors for Cyanosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Secondary Prevention

Secondary prevention in cyanotic congenital heart disease includes obtaining EKG Exercise stress test, Holter monitoring, Transthoracic echocardiography, Cardiac MRI, Cardiac CT Scan, Pulse oximetry every 12-60 months based on the stage of disease.

References

Template:WH Template:WS